|
2024
|
Invention
|
Vaccine composition against african swine fever virus. Chimeric antigens comprising a fragment of... |
|
|
Invention
|
Multitarget chimeric protein for immunotherapy of alzheimer's disease. The present invention is r... |
|
|
Invention
|
Formulation for immunization of pigs by the oral route. An immunogenic formulation by the oral ro... |
|
2023
|
Invention
|
Pharmaceutical composition comprising an apl type peptide.
The invention is relate with a pharma... |
|
|
Invention
|
Flowering-inducing composition. Brevibacterium celereBrevibacterium celereBrevibacterium celereBr... |
|
|
Invention
|
Peptide for the treatment of diseases associated with apolipoprotein ai or transthyretin involvem... |
|
2022
|
Invention
|
Proangiogenic growth factor-binding polypeptides. The present invention relates to proangiogenic ... |
|
|
Invention
|
Polypeptides that bind proangiogenic growth factors. The present invention relates to proangiogen... |
|
|
Invention
|
Chimeric antigens for the control of coronavirus and compositions containing same. Disclosed are ... |
|
|
Invention
|
Recombinant antigen for inducing an immune response against the zika virus.
Recombinant chimeric... |
|
|
Invention
|
Recombinant antigen for the induction of immune response against the zika virus. The invention re... |
|
|
Invention
|
Recombinant antigen for inducing an immune response against the zika virus. The invention relates... |
|
|
Invention
|
Linear peptides inhibiting ck2-mediated phosphorylation and compositions comprising same.
Linear... |
|
|
Invention
|
Linear peptides inhibiting ck2-mediated phosphorylation and compositions comprising same. Linear ... |
|
|
Invention
|
Linear peptides inhibiting ck2-mediated phosphorylation and compositions comprising thereof. Line... |
|
|
Invention
|
Modified levansucrase for the optimised production of fructooligosaccharides. Gluconacetobacter d... |
|
|
Invention
|
Modified levansucrase for the optimised production of fructooligosaccharides. The present inventi... |
|
|
Invention
|
Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b... |
|
|
Invention
|
Pharmaceutical composition containing ghrp-6.
Pharmaceutical composition comprising growth-hormo... |
|
|
Invention
|
Pharmaceutical composition containing ghrp-6. The present invention relates to a pharmaceutical c... |
|
2021
|
Invention
|
Peptides for the treatment of respiratory infections of viral origin. Peptides that have an amino... |
|
|
Invention
|
Cigb-210 and analogues for the treatment of respiratory infections of viral origin. Peptides that... |
|
|
Invention
|
Use of synthetic peptide for the induction of antitumor and antiviral immunity.
Use of the pepti... |
|
|
Invention
|
Cigb-300 for use in the the induction of antitumor and antiviral immunty. Use of the peptide iden... |
|
|
Invention
|
Use of synthetic peptide for the induction of antitumor and antiviral immunty. Use of the peptide... |
|
|
Invention
|
Vaccine composition comprising a mutant of human interleukin-15.
Vaccine composition containing ... |
|
|
Invention
|
Chimeric protein comprising the receptor binding domain of the corona virus spike protein and com... |
|
|
Invention
|
Chimeric protein comprising the receptor binding domain of the coronavirus spike protein and comp... |
|
|
Invention
|
Chimeric antigen comprising the extracellular domain of pd-l1.
Chimeric antigen comprising multi... |
|
|
Invention
|
Chimeric antigen comprising the extracellular domain of pd-l1. Chimeric antigen comprising the ex... |
|
|
Invention
|
Chimeric antigen comprising the extracellular domain of pd-l1. Chimeric antigen comprising multim... |
|
|
Invention
|
Peptide for treating coronavirus infections. The present invention relates to a peptide for the t... |
|
|
Invention
|
Pharmaceutical composition for the treatment of respiratory diseases of viral origin. A pharmaceu... |
|
|
Invention
|
Viral nucleoprotein and formulations containing same. The invention relates to a nucleoprotein co... |
|
|
Invention
|
Peptide for the treatment of cytokine storm syndrome.
Pharmaceutical composition comprising the ... |
|
|
Invention
|
Peptide for the treatment of cytokine storm syndrome. Disclosed is a pharmaceutical composition c... |
|
2020
|
Invention
|
Polypeptides comprising mutated forms of human vegf-a with rearrangements of disulfide bonds and ... |
|
|
Invention
|
Biopesticide and biofertilizer composition.
Biopesticide and biofertilizer composition comprisin... |
|
|
Invention
|
Use of epidermal growth factor in diabetic foot ulcer treatment.
The present invention reveals t... |
|
2019
|
Invention
|
Solid composition for agricultural and veterinary use.
Solid composition for agricultural or vet... |
|
|
Invention
|
Use of ghrp-6 as late cardioprotective and cardiac restoration medicament. The present invention ... |
|
|
Invention
|
Pharmaceutical combination comprising epidermal growth factor and secretagogue peptide ghrp6 for ... |
|
|
Invention
|
Hepatitis b vaccine transnasal administration system. The present invention relates to a rhinovac... |
|
2018
|
Invention
|
Interleukin-15 activity antagonist peptide.
The present invention discloses an antagonist peptid... |
|
|
Invention
|
Soy plants comprising the transgenic event cigbdt-def1 or cigbis-def5. The invention discloses a ... |
